Engineering the Saccharomyces cerevisiae β-oxidation pathway to increase medium chain fatty acid production as potential biofuel.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24465440.
- Also identified by DOI 10.1371/journal.pone.0084853 and PMC identifier 3897402.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Fatty acid-derived biofuels and biochemicals can be produced in microbes using β-oxidation pathway engineering. In this study, the β-oxidation pathway of Saccharomyces cerevisiae was engineered to accumulate a higher ratio of medium chain fatty acids (MCFAs) when cells were grown on fatty acid-rich feedstock. For this purpose, the haploid deletion strain Δpox1 was obtained, in which the sole acyl-CoA oxidase encoded by POX1 was deleted. Next, the POX2 gene from Yarrowia lipolytica, which encodes an acyl-CoA oxidase with a preference for long chain acyl-CoAs, was expressed in the Δpox1 strain. The resulting Δpox1 [pox2+] strain exhibited a growth defect because the β-oxidation pathway was blocked in peroxisomes. To unblock the β-oxidation pathway, the gene CROT, which encodes carnitine O-octanoyltransferase, was expressed in the Δpox1 [pox2+] strain to transport the accumulated medium chain acyl-coAs out of the peroxisomes. The obtained Δpox1 [pox2+, crot+] strain grew at a normal rate. The effect of these genetic modifications on fatty acid accumulation and profile was investigated when the strains were grown on oleic acids-containing medium. It was determined that the engineered strains Δpox1 [pox2+] and Δpox1 [pox2+, crot+] had increased fatty acid accumulation and an increased ratio of MCFAs. Compared to the wild-type (WT) strain, the total fatty acid production of the strains Δpox1 [pox2+] and Δpox1 [pox2+, crot+] were increased 29.5% and 15.6%, respectively. The intracellular level of MCFAs in Δpox1 [pox2+] and Δpox1 [pox2+, crot+] increased 2.26- and 1.87-fold compared to the WT strain, respectively. In addition, MCFAs in the culture medium increased 3.29-fold and 3.34-fold compared to the WT strain. These results suggested that fatty acids with an increased MCFAs ratio accumulate in the engineered strains with a modified β-oxidation pathway. Our approach exhibits great potential for transforming low value fatty acid-rich feedstock into high value fatty acid-derived products.
Medical subject headings
- Acyl Coenzyme A
- Acyl Coenzyme A/metabolism
- Acyl-CoA Oxidase
- Acyl-CoA Oxidase/deficiency
- Acyl-CoA Oxidase/genetics
- Biofuels
- Carnitine Acyltransferases
- Carnitine Acyltransferases/genetics
- Carnitine Acyltransferases/metabolism
- Cytoplasm
- Cytoplasm/enzymology
- Fatty Acids
- Fatty Acids/biosynthesis
- Isoenzymes
- Isoenzymes/genetics
- Isoenzymes/metabolism
- Metabolic Engineering
- Oxidation-Reduction
- Peroxisomes
- Peroxisomes/enzymology
- Saccharomyces cerevisiae
- Saccharomyces cerevisiae/enzymology
- Saccharomyces cerevisiae/genetics
- Saccharomyces cerevisiae Proteins
- Saccharomyces cerevisiae Proteins/genetics
- Transgenes
- Yarrowia
- Yarrowia/chemistry
- Yarrowia/enzymology